This infographic explores requirements critical to container closure integrity in packaging as you start and scale production of your drug product.
Getting drugs to market quickly and safely depends on reliable containment. Critical to ensuring safe storage and delivery is container closure integrity (CCI). CCI not only delivers your product, but it also prevents contamination and ensures quality throughout shelf life. As drug development continues to grow globally, including in diverse therapeutic targets, the combination of seal, stopper, and vial in containment solutions is also a key part of scaling production.
This infographic explores three must-haves in containment solutions in accelerating drugs to market. CCI components can also reduce risks associated with selecting individual components that may not work well together. Highlights include:
- How ready-to-use drug packaging can support speed to market.
- The expertise that’s critical to meeting global requirements for packaging and containment.
- How one containment partner provides flexibility and is ideal for early-stage development or small-volume filling.
Offered Free by: BioPharma Dive’s Studio by Informa TechTarget and West Pharmaceutical Services
See All Resources from: BioPharma Dive’s Studio by Informa TechTarget and West Pharmaceutical Services
